Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: NANODE THERAPEUTICS, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-30 to 2023-09-29
Current total value of award: $441150.3
Description: DEVELOPING A NOVEL NON-VIRAL NANOPIECES GENE DELIVERY SYSTEM FOR AD GENE THERAPY